Merck Sharp & Dohme Corp.'s Net Worth

$0

Estimate Recalculated Nov 1, 2024 09:21AM EST

Who is Merck Sharp & Dohme Corp.?

Merck Sharp & Dohme Corp. does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include OPGEN INC, BeiGene, Ltd., ARQULE INC, NGM BIOPHARMACEUTICALS INC, SUTRO BIOPHARMA INC, and Menlo Therapeutics Inc..

SEC CIK

Merck Sharp & Dohme Corp.'s CIK is 0000942443

Past Insider Trading and Trends

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

OPGEN INC (OPGN) Snapshot price: $2.05

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+102.07%
2.73M
—
—
5.41M
Jun 27
Form 4
+81.13%
1.2M
—
—
2.68M
May 19
Form 3
—
0
—
—
0
No matching records found

BeiGene, Ltd. (BGNE) Snapshot price: $191.32

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
31.59M
—
—
31.59M
Feb 8
Form 3
—
0
—
—
0
No matching records found

ARQULE INC No price found

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found

NGM BIOPHARMACEUTICALS INC (NGM) No price found

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
12.96M
$16.00
—
12.96M
Apr 8
Form 3
—
0
—
—
0
No matching records found

SUTRO BIOPHARMA INC (STRO) Snapshot price: $4.12

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
2.72M
$15.00
—
2.72M
Oct 1
Form 3
—
0
—
—
0
No matching records found